β-amyloid
Decreased levels of soluble amyloid β protein precursor and β amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus
8
β-amyloid deposition is shifted to the vasculature and memory impairment is exacerbated when hyperhomocysteinemia is induced in APP/PS1 transgenic mice
11
Modulation of β-amyloid precursor protein trafficking and processing by the low density lipoprotein receptor family
13
Crystal structure reveals conservation of amyloid-β conformation recognized by 3D6 following humanization to bapineuzumab
13
Identification of the novel activity-driven interaction between synaptotagmin 1 and presenilin 1 links calcium, synapse, and amyloid beta
24
Decreasing the expression of PICALM reduces endocytosis and the activity of β secretase: Implications for Alzheimer's disease
17
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
11
Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer’s disease dementia in mild cognitive impairment
15
Aqueous extract from the Withania somnifera leaves as a potential anti-neuroinflammatory agent: a mechanistic study
17
Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer’s disease
12
Induced pluripotent stem cells in Alzheimer’s disease: applications for disease modeling and cell-replacement therapy
11
Prophylactic melatonin significantly reduces Alzheimer’s neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPPswe/PS1 mice
21
Stepping closer to treating Alzheimer’s disease patients with BACE1 inhibitor drugs
11
Cross-talk of membrane lipids and Alzheimer-related proteins
12
Cerebral amyloid angiopathy-related inflammation: a case report presenting with a rare variant in SORL1 gene
6
Involvement of 5-lipoxygenase activating protein in the amyloidotic phenotype of an Alzheimer’s disease mouse model
10
Alzheimer’s disease and immunotherapy: what is wrong with clinical trials?
8
Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer's disease
14
RIG-1 receptor expression in the pathology of Alzheimer’s disease
9
Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy
16